Verallo, Jann Ciel P.

HRN: 26-90-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2025
OXACILLIN 500MG (VIAL)
03/31/2025
04/06/2025
IV
250
Q6
Staphylococcal Skin Infection
Waiting Final Action 
03/31/2025
MUPIROCIN 2%, 15G (TUBE)
03/31/2025
04/06/2025
TOPICAL
Thinly
TID
Staphylococcal Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: